Form 4 for WST West Pharmaceutical Services
Accepted 2023-08-24 00:00:00 ET · period of report 2023-08-22 · accession 0001562180-23-006564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-24 | 2023-08-22 | WST | Reiss-Clark Cindy | Chief Commercial Off | S - Sale+OE | $393.34 | -3,477 | 4,320 | -45% | -$1.37M |
| DM | 2023-08-24 | 2023-08-22 | WST | Reiss-Clark Cindy | Chief Commercial Off | M - OptEx | $263.16 | +3,477 | 7,020 | +98% | +$915.0K |
| DM | 2023-08-24 | 2023-08-22 | WST | Reiss-Clark Cindy | Chief Commercial Off | M - OptEx | $393.34 | -3,477 | 1,588 | -69% | -$1.37M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-22 | S | D | 3,477 | $393.34 | 4,320.16 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-22 | M | A | 777 | $369.13 | 7,797.16 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-22 | M | A | 1,112 | $173.22 | 5,432.16 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-22 | M | A | 1,588 | $274.29 | 7,020.16 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2023-08-22 | M | D | 1,112 | $393.34 | 1,756 | D | $173.22 · 2021-02-18 to 2030-02-18 | 1,112 Common Stock | (F3) This award vests in four equal annual installments beginning on February 18, 2021. |
| 6 | Derivative | Stock Options (Right to buy) | 2023-08-22 | M | D | 777 | $393.34 | 2,331 | D | $369.13 · 2023-02-22 to 2032-02-22 | 777 Common Stock | (F1) This award vests in four equal annual installments beginning on February 22, 2023. |
| 7 | Derivative | Stock Options (Right to buy) | 2023-08-22 | M | D | 1,588 | $393.34 | 1,588 | D | $274.29 · 2022-02-23 to 2031-02-23 | 1,588 Common Stock | (F2) This award vests in four equal annual installments beginning on February 23, 2022. |